Targetsite Therapeutics Corporation

Biotechnology company · New Haven, Connecticut, United States

Targetsite Therapeutics Corporation is a biotechnology company headquartered in New Haven, Connecticut, United States. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $564,794 in total, most recently in 2023.

Profile compiled from public records. Is this your company? Request a correction or update

Targetsite Therapeutics at a glance

Typebiotechnology company

HeadquartersNew Haven, Connecticut, United States

Employees (self-reported, 2023)3

What does Targetsite Therapeutics do?

US government research funding

2 SBIR/STTR small-business research awards from US health agencies, $564,794 in total (2021 to 2023). NIH funding came from the National Eye Institute, National Heart, Lung, and Blood Institute.

Frequently asked questions about Targetsite Therapeutics

Where is Targetsite Therapeutics headquartered?

Targetsite Therapeutics Corporation is headquartered in New Haven, Connecticut, United States.

What does Targetsite Therapeutics do?

Targetsite Therapeutics Corporation is a biotechnology company.

Similar companies

Allyx Therapeutics, Inc.New Haven, Connecticut, United States
Invivyd, Inc.New Haven, Connecticut, United States
ReNetX Bio, Inc.New Haven, Connecticut, United States
AtlasXomics Inc.New Haven, Connecticut, United States
Vion Pharmaceuticals IncNew Haven, Connecticut, United States
ProteoWise Inc.New Haven, Connecticut, United States
Oui Therapeutics IncNew Haven, Connecticut, United States
Modifi Biosciences, Inc.New Haven, Connecticut, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences